CH654744A5 - Waessrige pharmazeutische formulierung auf basis eines vincaalkaloids. - Google Patents

Waessrige pharmazeutische formulierung auf basis eines vincaalkaloids. Download PDF

Info

Publication number
CH654744A5
CH654744A5 CH3808/83A CH380883A CH654744A5 CH 654744 A5 CH654744 A5 CH 654744A5 CH 3808/83 A CH3808/83 A CH 3808/83A CH 380883 A CH380883 A CH 380883A CH 654744 A5 CH654744 A5 CH 654744A5
Authority
CH
Switzerland
Prior art keywords
vincristine
sulfate
solution
formulation according
alkaloids
Prior art date
Application number
CH3808/83A
Other languages
German (de)
English (en)
Inventor
Robert Lee Robison
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CH654744A5 publication Critical patent/CH654744A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CH3808/83A 1982-07-19 1983-07-11 Waessrige pharmazeutische formulierung auf basis eines vincaalkaloids. CH654744A5 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39965482A 1982-07-19 1982-07-19
US47607783A 1983-03-17 1983-03-17

Publications (1)

Publication Number Publication Date
CH654744A5 true CH654744A5 (de) 1986-03-14

Family

ID=27016716

Family Applications (1)

Application Number Title Priority Date Filing Date
CH3808/83A CH654744A5 (de) 1982-07-19 1983-07-11 Waessrige pharmazeutische formulierung auf basis eines vincaalkaloids.

Country Status (16)

Country Link
AU (1) AU553514B2 (nl)
BE (1) BE897280A (nl)
CH (1) CH654744A5 (nl)
DE (1) DE3324964A1 (nl)
FR (1) FR2531860B1 (nl)
GB (1) GB2125292B (nl)
HK (1) HK43087A (nl)
HU (1) HU191538B (nl)
IE (1) IE55388B1 (nl)
IL (1) IL69203A (nl)
IT (1) IT1170152B (nl)
LU (1) LU84910A1 (nl)
NL (1) NL184146C (nl)
NZ (1) NZ204868A (nl)
PH (1) PH19098A (nl)
SE (1) SE463804B (nl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU195513B (en) * 1984-10-16 1988-05-30 Richter Gedeon Vegyeszet Process for producing stable solutions of alkaloides with bis-indole skeleton
FR2597750B1 (fr) * 1986-04-25 1989-06-02 Pf Medicament Solution aqueuse stable de sulfate de vincristine
FR2623089B1 (fr) * 1987-11-13 1990-04-27 Pf Medicament Composition pharmaceutique pour l'administration parenterale de navelbine
US4923876A (en) * 1988-04-18 1990-05-08 Cetus Corporation Vinca alkaloid pharmaceutical compositions
HU204995B (en) * 1989-11-07 1992-03-30 Richter Gedeon Vegyeszet Process for producing pharmaceutical composition comprising alkaloid with bis-indole skeleton, with antitumour activity and suitable fr parenteral purposes
FR2910812B1 (fr) * 2006-12-29 2009-03-20 Pierre Fabre Medicament Sa Compositions pharmaceutiques injectables lyophilisees de derives hemi-synthetiques d'alcaloide de vinca stables a temperature ambiante
EP3328385B1 (en) * 2015-08-01 2020-07-08 Sun Pharmaceutical Industries Ltd Dosage form of vinca alkaloid drug

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3097137A (en) * 1960-05-19 1963-07-09 Canadian Patents Dev Vincaleukoblastine
US3749784A (en) * 1972-05-03 1973-07-31 Lilly Co Eli Psoriasis treatment
GB2020180B (en) * 1978-05-08 1982-08-25 Nelson Res & Dev Ophthalmic compositions containingcolchicine or vinblastinr
US4208414A (en) * 1978-06-05 1980-06-17 Eli Lilly And Company Vinblastine in rheumatoid arthritis
US4259242A (en) * 1978-10-10 1981-03-31 Eli Lilly And Company Method of preparing vindesine sulfate
HU181940B (en) * 1979-11-02 1983-11-28 Richter Gedeon Vegyeszet Process for producing solutions of vincane derivatives for parentheral application
OA06421A (fr) * 1980-06-10 1981-09-30 Omnium Chimique Sa Procédé de préparation de dérivés N-(vinblastinoyl-23) d'acides aminés et de peptides.

Also Published As

Publication number Publication date
IT1170152B (it) 1987-06-03
NL184146C (nl) 1989-05-01
PH19098A (en) 1986-01-02
IL69203A0 (en) 1983-11-30
NZ204868A (en) 1986-10-08
GB8319146D0 (en) 1983-08-17
FR2531860A1 (fr) 1984-02-24
SE463804B (sv) 1991-01-28
SE8304009L (sv) 1984-01-20
IE55388B1 (en) 1990-08-29
LU84910A1 (fr) 1985-04-17
AU553514B2 (en) 1986-07-17
NL184146B (nl) 1988-12-01
DE3324964A1 (de) 1984-01-19
HU191538B (en) 1987-03-30
BE897280A (fr) 1984-01-13
SE8304009D0 (sv) 1983-07-15
IE831646L (en) 1984-01-19
AU1689183A (en) 1984-01-26
DE3324964C2 (nl) 1991-03-14
IL69203A (en) 1986-03-31
FR2531860B1 (fr) 1986-09-26
HK43087A (en) 1987-06-05
GB2125292B (en) 1986-06-04
GB2125292A (en) 1984-03-07
IT8321644A0 (it) 1983-06-15
NL8302552A (nl) 1984-02-16

Similar Documents

Publication Publication Date Title
DE69834956T2 (de) Stabile Insulinformulierungen
DE69519300T2 (de) Stabiles arzneimittel enthaltend oxaliplatin
EP2046332B1 (de) Konzentrierte methotrexat-lösungen
EP1037648B1 (de) Verwendung von erythropoietin und eisenpräparaten zur herstellung von pharmazeutischen kombinationspräparaten zur behandlung von rheumatischen erkrankungen
DE60038118T2 (de) Formulierungen von wachstumshormonen
DE3621844C2 (de) Injizierbare, Doxorubicin-enthaltende Lösung und Verfahren zur Herstellung derselben
DE19535571A1 (de) Pharmazeutische Kombinationspräparate und deren Verwendung zur Behandlung von Hämodialysepatienten
WO2001078732A1 (de) Lagerstabile infusionslösung des ciprofloxacins
DE3536560A1 (de) Augentropfen enthaltend bromokryptin
DE68902300T2 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.
US4619935A (en) Stable oncolytic formulations
DE3324964C2 (nl)
DE2920020C2 (nl)
DE3751589T2 (de) Anthracyclin-Glucosid enthaltende einspritzbare gebrauchsfertige Lösungen gegen Krebs.
DE60101979T2 (de) Lösung enthaltend N-[O-(p-pivaloyloxybenzenesulfonylamino)benzoyl]glyzin Mononatriumsalz Tetrahydrat und diese Lösung enthaltendes Arzneimittel
DE60220766T2 (de) Verwendung eines eine oxaliplatinlösung beinhaltenden fläschchens
EP0363502B1 (de) Flüssiges, wismuthaltiges Arzneipräparat, Verfahren zum Herstellen desselben und seine Verwendung
EP0591710A1 (de) Mesna-Injektionslösungen
WO1998058639A1 (de) Synergistisch wirkende zusammensetzungen zur selektiven bekämpfung von tumorgewebe
DE2546474A1 (de) Injizierbares pharmazeutisches thyroxinpraeparat und verfahren zu dessen herstellung
DE68902755T2 (de) Antineoplastische formulierungen.
DE2721034C2 (nl)
DE3883525T2 (de) Mikrokristalline matritze zur verabreichung eines heilmittels.
DE2633943A1 (de) Oral oder parenteral zu verabreichende loesung eines oxazepins
DE2522081C2 (nl)

Legal Events

Date Code Title Description
PL Patent ceased